Coughing; that itching is undercontrol and is wide spread but stated that the side effects are relatively under control; Vaccination failure; Tested positive for covid on 27Dec2021; developed incredibly badhives and urticaria; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (developed incredibly badhives and urticaria), COUGH (Coughing), COVID-19 (Tested positive for covid on 27Dec2021), PRURITUS (that itching is undercontrol and is wide spread but stated that the side effects are relatively under control) and VACCINATION FAILURE (Vaccination failure) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Dec-2021, the patient experienced URTICARIA (developed incredibly badhives and urticaria). On 27-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Tested positive for covid on 27Dec2021). On an unknown date, the patient experienced COUGH (Coughing), PRURITUS (that itching is undercontrol and is wide spread but stated that the side effects are relatively under control) and VACCINATION FAILURE (Vaccination failure). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (developed incredibly badhives and urticaria) had not resolved, COUGH (Coughing), COVID-19 (Tested positive for covid on 27Dec2021) and VACCINATION FAILURE (Vaccination failure) outcome was unknown and PRURITUS (that itching is undercontrol and is wide spread but stated that the side effects are relatively under control) was resolving.            Concomitant medication information was not provided by the reporter.  Treatment Medications included high dose anti-histamines.  Company Comment: This is a Spontaneous case concerning a 27-year-old female patient, with no medical history reported, who experienced the unexpected, nonserious, and AESI event of COVID-19, and the additional event of Vaccination failure. The event occurred 27 days after the third dose of mRNA-1273 vaccine. The patient completed primary vaccination for COVID-19 with mRNA-1273 vaccine, and received booster dose 7 months later. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-439467, MOD-2022-439468, MOD-2022-439235 (Patient Link).; Sender's Comments: This is a Spontaneous case concerning a 27-year-old female patient, with no medical history reported, who experienced the unexpected, nonserious, and AESI event of COVID-19, and the additional event of Vaccination failure. The event occurred 27 days after the third dose of mRNA-1273 vaccine. The patient completed primary vaccination for COVID-19 with mRNA-1273 vaccine, and received booster dose 7 months later. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.